Artificial intelligence and machine learning companies develop software, algorithms and computational platforms that analyse biological data, automate workflows and accelerate scientific discovery. These technologies are increasingly used across drug discovery, diagnostics, genomics and healthcare research.
This category includes companies working on:
Browse 243 UK AI and machine learning companies below.
AI analysis of brain MRI for neurological diagnosis and prognosis
Ainostics is a medical artificial intelligence company developing software that analyses brain scans and clinical data to support the diagnosis and prognosis of neurological disorders. Its platform derives detailed measures of brain tissue structure from routine MRI and compares them with healthy populations to detect…
AI-driven target discovery from human tissue omics
Relation is a platform biotechnology company integrating machine learning with single-cell and spatial multi-omics data derived directly from patient tissue to discover and validate novel drug targets. Its initial research focus is bone biology, with a proprietary observational study generating deeply characterised…
AI-powered dental X-ray diagnostic software
BeCertain develops AI-powered software for interpreting dental X-rays. Its machine learning models are trained on annotated radiograph datasets to help clinicians detect caries, periodontal disease and other oral abnormalities. The company is a joint spinout from King's College London and the University of Surrey, and…
Quantitative digital pathology image analysis services for pharma
OracleBio is a contract research organisation specialising in quantitative digital pathology and histopathology image analysis. The company delivers high-precision tissue biomarker quantification services to pharmaceutical and biotechnology clients, supporting pre-clinical and clinical research programmes. Services…
Blood biomarker diagnostics for fish health monitoring in aquaculture
WellFish Tech is a contract research organisation providing non-lethal blood-based biomarker diagnostics for the global aquaculture industry. The service analyses clinical chemistry markers from fish blood samples to assess health status, detect early signs of disease, and inform management decisions on treatment,…
AI platform integrating biology, chemistry and automation for drug discovery
Recursion is a clinical-stage biotechnology company using AI and robotic wet-lab automation to industrialise small molecule drug discovery. Its platform integrates phenomics, transcriptomics, proteomics and patient data to identify and optimise drug candidates at scale. Following its acquisition of Oxford-based…
AI-driven combinatorial analytics platform for chronic disease biology
PrecisionLife is a computational biology company applying AI-driven combinatorial analytics to complex chronic diseases. Its platform identifies causal biological mechanisms and patient subgroups at a resolution not achievable by conventional genomic methods, enabling novel drug target discovery, patient…
AI-driven precision therapeutics for metabolic syndrome diseases
Multiomic Health is a data-centric therapeutics company developing precision medicines for metabolic syndrome-related conditions, including type 2 diabetes, cardiovascular disease, chronic kidney disease and non-alcoholic fatty liver disease. The company integrates multi-omics data with longitudinal clinical datasets…
Single-cell genomics and AI platform for autoimmune and fibrotic disease
Ensocell is a Cambridge-based biotechnology company developing precision biologics for autoimmune, inflammatory, and fibrotic diseases. Its platform integrates single-cell and spatial genomics with AI-based computational tools and advanced cell models to identify novel disease intervention points and design targeted…
AI-powered fertility diagnostics and remote patient pathway platform
Enhanced Fertility is a digital health company providing software and at-home testing services for fertility diagnosis and treatment planning. The company's platform supports patients with remote biomarker testing and personalised fertility assessments, and offers clinics an AI-assisted portal for managing…
Medical imaging CRO and AI platform for clinical trials
Image Analysis Group is a specialist imaging contract research organisation serving biotech and pharmaceutical companies across all clinical trial phases. The company designs and executes imaging-based efficacy and safety endpoints, provides centralised independent radiological review, and delivers quantitative image…
Academic protein informatics and antibody modelling tools
Oxford Protein Informatics Group is a University of Oxford research team led by Professor Charlotte Deane, developing computational methods for protein structures and interactions. Its researchers apply machine learning and bioinformatics to antibody modelling, immunoinformatics, protein engineering and drug…
Computationally designed broadly protective vaccines against pandemic viruses
DIOSynVax is a clinical-stage biotechnology company developing broadly protective vaccines using a computational antigen design platform. The company's technology applies protein structure modelling and immune optimisation to engineer synthetic vaccine antigen payloads targeting conserved regions of viruses, enabling…
AI-enabled personalised dosing for drug-digital combination therapies
Closed Loop Medicine develops combination products integrating pharmaceutical therapies with AI-powered digital companions to personalise drug dosing for chronic conditions. Its platform applies pharmacometric modelling and patient response data to optimise treatment regimens. The pipeline includes co-packaged drug…
AI drug discovery platform developing novel biologics for cancer and AMR
AMPLY Discovery is a biotechnology company developing an AI-driven drug discovery platform that combines machine learning, next-generation sequencing, and synthetic biology to identify novel biologic drug candidates from natural biological diversity. The platform digitises biological molecules, identifies treatment…
CRISPR genome editing and engineered cell models for research
Prime.io is a contract research organisation providing genome editing services and reagents for drug discovery and functional genomics. Its work includes CRISPR knock-in and knock-out cell line generation, gene editing design, pooled screening and sequencing-based validation. The company develops engineered cellular…
AI-native virtual scientist platform for drug discovery
Kiin Bio is a software company developing an AI-native platform that integrates virtual scientist agents with laboratory databases, modelling software and analysis tools to streamline drug discovery workflows. The platform coordinates tasks spanning literature review, experimental design, bioinformatics and…
Organ-specific liquid biopsy tests for early cancer detection
Mursla Bio is a diagnostics company developing blood-based tests for early cancer detection using extracellular vesicle biology. Its platform isolates organ-specific extracellular vesicles from blood and applies multi-omics profiling and machine learning to identify disease biomarkers without tissue biopsy. Its lead…
RNA-targeted drug discovery platform using machine learning
RevoNA Bio is a biotechnology company developing a high-throughput RNA biological platform for RNA-targeted drug discovery. The platform generates comprehensive RNA structural and functional datasets that feed a machine learning predictive engine, supporting hit identification, structure-activity relationship…
Regulatory-compliant medical AI software and connected device development
Camgenium is a medical technology software company specialising in the development and deployment of AI-driven medical device software and connected hardware. Operating to ISO 13485, ISO 27001 and GxP standards, the company offers end-to-end services spanning product concept, development, production, and deployment.…